Navellier & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $313K | Sell |
2,600
-86
| -3% | -$9.93K | 0.03% | 277 |
|
|
2025
Q4 | $283K | Sell |
2,686
-5,707
| -68% | -$536K | 0.03% | 283 |
|
|
2025
Q3 | $704K | Buy |
8,393
+244
| +3% | +$20.1K | 0.07% | 216 |
|
|
2025
Q2 | $645K | Hold |
8,149
| – | – | 0.08% | 185 |
|
|
2025
Q1 | $675K | Sell |
8,149
-6,604
| -45% | -$617K | 0.09% | 175 |
|
|
2024
Q4 | $1.47M | Buy |
14,753
+2,035
| +16% | +$210K | 0.18% | 123 |
|
|
2024
Q3 | $1.44M | Sell |
12,718
-2,761
| -18% | -$328K | 0.2% | 109 |
|
|
2024
Q2 | $1.92M | Sell |
15,479
-86
| -0.6% | -$11.1K | 0.23% | 102 |
|
|
2024
Q1 | $2.05M | Sell |
15,565
-921
| -6% | -$114K | 0.25% | 97 |
|
|
2023
Q4 | $1.8M | Buy |
16,486
+2,756
| +20% | +$286K | 0.27% | 97 |
|
|
2023
Q3 | $1.41M | Buy |
13,730
+3,994
| +41% | +$430K | 0.24% | 108 |
|
|
2023
Q2 | $1.12M | Buy |
9,736
+382
| +4% | +$43.4K | 0.22% | 112 |
|
|
2023
Q1 | $995K | Sell |
9,354
-1,089
| -10% | -$118K | 0.21% | 107 |
|
|
2022
Q4 | $1.16M | Buy |
10,443
+516
| +5% | +$52.7K | 0.24% | 99 |
|
|
2022
Q3 | $855K | Sell |
9,927
-470
| -5% | -$42K | 0.19% | 113 |
|
|
2022
Q2 | $948K | Buy |
10,397
+99
| +1% | +$8.78K | 0.2% | 114 |
|
|
2022
Q1 | $845K | Sell |
10,298
-127
| -1% | -$10K | 0.14% | 133 |
|
|
2021
Q4 | $799K | Sell |
10,425
-562
| -5% | -$44.8K | 0.12% | 155 |
|
|
2021
Q3 | $825K | Sell |
10,987
-536
| -5% | -$40.8K | 0.12% | 153 |
|
|
2021
Q2 | $896K | Sell |
11,523
-734
| -6% | -$54.6K | 0.14% | 148 |
|
|
2021
Q1 | $902K | Sell |
12,257
-780
| -6% | -$57.5K | 0.16% | 127 |
|
|
2020
Q4 | $1.02M | Sell |
13,037
-448
| -3% | -$34.3K | 0.18% | 114 |
|
|
2020
Q3 | $1.07M | Sell |
13,485
-1,331
| -9% | -$104K | 0.23% | 100 |
|
|
2020
Q2 | $1.09M | Buy |
14,816
+10,926
| +281% | +$823K | 0.26% | 93 |
|
|
2020
Q1 | $286K | Sell |
3,890
-5,293
| -58% | -$416K | 0.07% | 179 |
|
|
2019
Q4 | $797K | Buy |
9,183
+262
| +3% | +$21.5K | 0.13% | 153 |
|
|
2019
Q3 | $717K | Sell |
8,921
-97
| -1% | -$7.77K | 0.12% | 159 |
|
|
2019
Q2 | $722K | Sell |
9,018
-422
| -4% | -$32.3K | 0.11% | 155 |
|
|
2019
Q1 | $749K | Sell |
9,440
-308
| -3% | -$23K | 0.12% | 140 |
|
|
2018
Q4 | $711K | Buy |
9,748
+4,925
| +102% | +$348K | 0.12% | 125 |
|
|
2018
Q3 | $326K | Sell |
4,823
-7,859
| -62% | -$501K | 0.04% | 228 |
|
|
2018
Q2 | $735K | Sell |
12,682
-1,152
| -8% | -$65K | 0.1% | 165 |
|
|
2018
Q1 | $719K | Sell |
13,834
-2,279
| -14% | -$123K | 0.11% | 156 |
|
|
2017
Q4 | $865K | Sell |
16,113
-33,117
| -67% | -$1.84M | 0.16% | 142 |
|
|
2017
Q3 | $3.01M | Sell |
49,230
-10,811
| -18% | -$655K | 0.58% | 51 |
|
|
2017
Q2 | $3.67M | Sell |
60,041
-3,468
| -5% | -$211K | 0.55% | 54 |
|
|
2017
Q1 | $3.85M | Sell |
63,509
-1,781
| -3% | -$108K | 0.56% | 72 |
|
|
2016
Q4 | $3.67M | Sell |
65,290
-5,664
| -8% | -$331K | 0.61% | 70 |
|
|
2016
Q3 | $4.22M | Sell |
70,954
-2,408
| -3% | -$141K | 0.6% | 61 |
|
|
2016
Q2 | $4.03M | Buy |
73,362
+2,772
| +4% | +$148K | 0.6% | 53 |
|
|
2016
Q1 | $3.56M | Buy |
70,590
+3,033
| +4% | +$149K | 0.46% | 50 |
|
|
2015
Q4 | $3.4M | Buy |
67,557
+257
| +0.4% | +$13K | 0.37% | 49 |
|
|
2015
Q3 | $3.17M | Buy |
67,300
+1,474
| +2% | +$78.3K | 0.32% | 50 |
|
|
2015
Q2 | $3.58M | Buy |
65,826
+9,118
| +16% | +$511K | 0.31% | 42 |
|
|
2015
Q1 | $3.11M | Buy |
56,708
+2,837
| +5% | +$161K | 0.28% | 47 |
|
|
2014
Q4 | $2.92M | Buy |
53,871
+5,274
| +11% | +$294K | 0.15% | 42 |
|
|
2014
Q3 | $2.75M | Buy |
48,597
+3,249
| +7% | +$182K | 0.14% | 50 |
|
|
2014
Q2 | $2.5M | Buy |
45,348
+19,370
| +75% | +$1.06M | 0.11% | 56 |
|
|
2014
Q1 | $1.41M | Buy |
25,978
+7,094
| +38% | +$367K | 0.07% | 76 |
|
|
2013
Q4 | $902K | Buy |
18,884
+2,888
| +18% | +$132K | 0.04% | 110 |
|
|
2013
Q3 | $727K | Buy |
15,996
+10,532
| +193% | +$481K | 0.02% | 148 |
|
|
2013
Q2 | $242K | Buy |
+5,464
| New | +$244K | 0.01% | 241 |
|
Other funds holding MRK
VCM
VPM
Navellier & Associates's MRK Position: Q1 2026 in Review
Navellier & Associates reduced its Merck (MRK) stake by 3.2% in Q1 2026, selling an estimated $9.93K and leaving 2,600 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #277.
Navellier & Associates first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.22M in Q3 2016. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Navellier & Associates held 2,600 shares of Merck worth $313K as of Q1 2026.
- Navellier & Associates sold 86 Merck shares in Q1 2026, an estimated $9.93K.
- Merck made up 0.03% of Navellier & Associates's portfolio in Q1 2026, its #277 holding.
- Navellier & Associates first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Navellier & Associates's Merck position peaked at $4.22M in Q3 2016.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.